期刊文献+

F基因型腮腺炎减毒活疫苗的临床前安全性评价 被引量:4

Preclinical Safety Evaluation of F Genotype Live Attenuated Mumps Vaccine
下载PDF
导出
摘要 目的观察F基因型腮腺炎减毒活疫苗的急性毒性及长期毒性试验效果。方法取前期制备的F基因型腮腺炎减毒活疫苗进行大鼠急性毒性试验,之后进行临床症状监测及大体病理学检查;并采用恒河猴进行长期毒性试验,之后观察试验动物的临床症状,进行血液学、生化检测、CD4+、CD8+细胞比例检测、病毒血症检测、病毒在组织器官的分布检测以及病理检查。结果急性毒性试验表明给予大鼠相当于人用剂量的1200倍剂量时,无论是临床症状监测还是大体病理学检查,均无明显异常;而长期毒性试验结果表明,恒河猴3次免疫8倍人用剂量时,疫苗对动物临床症状、血液学和血清生化指标无明显影响,CD4+、CD8+细胞比值亦无明显改变,动物的血液及组织器官中均未检出腮腺炎病毒RNA,各组织器官未见明显大体病理学改变。结论 F基因型腮腺炎减毒活疫苗的急性毒性试验及长期毒性试验均无明显异常,充分验证了疫苗的安全性,从而为疫苗进入临床试验提供了数据支持并奠定了基础。 Objective To observe the effect of acute toxicity and long - term toxicity test for F genotype live attenuated mumps vac- cine. Methods Acute toxicity test was taken in rats with the pre - preparation of F genotype live attenuated mumps vaccine. Then we monitored the clinical symptoms and examined the general pathology. Longterm toxicity test was carried out with rhesus monkeys, and the clinical symptoms, hematological, biochemical detection, CD4 + , CD8 + cell ratio, viremia detection, virus distribution of tissues and organs and pathology detection were studied. Results Acute toxicity test showed there were no obvious abnormalities whether in clinical symptoms or in gross pathological examination when the rats were given the dose equivalent to 1200 times the human dose. Long - term tox- icity test showed that when third immunized the rhesus monkeys with the dose equivalent to 8 times of the human dose, there was no signif- icant effect against animal clinical symptoms, hematology and serum biochemical detection, and there was no obvious change in CD4 + and CD8 + cell ratio. Mumps virus RNA was not detected in blood, tissues and organs, as well as there were no significant general pathological changes in tissues and organs. Conclusion The safety of the F genotype mumps live attenuated vaccine was fully verified when there were no significantly abnormal issues in the acute toxicity test and long - term toxicity tests, which provided data and laid the foundation for the vaccine entering the clinical trials.
出处 《医学研究杂志》 2013年第5期30-34,共5页 Journal of Medical Research
基金 国家"863"计划项目(2012AA02A404) "十二五"重大新药创制国家科技重大专项基金资助项目(2012ZX09101319) 国家科技重大专项基金资助项目(2009ZX10004-308) 云南省应用基础研究重点项目(2008CC018)
关键词 F基因型 腮腺炎减毒活疫苗 急性毒性试验 长期毒性试验 F genotype Mumps live attenuated vaccine Acute toxicity test Long- term toxicity tests
  • 相关文献

参考文献10

  • 1Sauder CJ, Zhang CX, Ngo L, et al. Gene - specific contributions to mumps virus neurovirulence and neuroattenuation[ J]. J Virol, 2011, 85(14) :7059 -7069. 被引量:1
  • 2Gupta RK, Registrar S, Beat J ,et al. Mumps and the UK epidemic [J]. BMJ,2005,330(7500) :1132 _ 1135. 被引量:1
  • 3Carr MJ, Moss E, Waters A, et al. Molecular epidemiological evaluation of the recent resurgence in mumps virus infectious in Ireland [ J ]. J Clin Microbiol, 2010,48(9) :3288 -3294. 被引量:1
  • 4杨文震,陈志慧.腮腺炎病毒的基因分型及当前疫苗的免疫效果[J].国外医学(预防.诊断.治疗用生物制品分册),2005,28(2):49-52. 被引量:38
  • 5Wu L, Bai L, Li Y, et al. Wild type mumps viruses circulating inChina establish a new genotype[ J]. Vaccine, 1998 ,16(7 ) :281 - 285. 被引量:1
  • 6马绍辉,张蓉松,刘龙丁,王晶晶,王丽春,杨文军,梁燕,杨子江,李琦涵.腮腺炎病毒分离株(SP株)SH基因及其旁侧序列的初步分析[J].微生物与感染,2006,1(2):87-90. 被引量:7
  • 7Cortese MM, Barskey AE, Tegtmeier GE, et al. Mumps antibody levels among students before a mumps outbreak : in search of a correlate of immunity [J]. J Infection Diseases ,2011 ,204( 1) :1413 - 1422. 被引量:1
  • 8Rubin SA, Link MA, Sauder CJ, et al. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape[ J ]. J Virol, 2012,86(1) :615 -620. 被引量:1
  • 9史长军,梁燕,崔萍芳,马绍辉,王庆玲,杨丽仙,陈巍,沈冬,谭振国,李琦涵.不同代次F基因型SP-A株腮腺炎病毒在恒河猴体内的致病性[J].中国生物制品学杂志,2008,21(9):774-776. 被引量:3
  • 10Liang Y, Ma SH, Liu LD, et al. Identification and development of a promising novel mumps vaccine candidate strain [ J ]. Microbes And Infection,2010,12(1) :1178 -1187. 被引量:1

二级参考文献38

共引文献44

同被引文献103

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部